Brasilia (AFP) Dec 15, 2020
The Brazilian health regulator Anvisa on Monday accused China of using criteria that “are not transparent” to win emergency approval of its coronavirus vaccine CoronaVac, which is in the final phase of trials in Brazil. “The Chinese criteria applied to grant the authorization of emergency use in China are not transparent,” Anvisa said in a statement. The regulator, which sent a group o
http://dlvr.it/Rng821